Thrombophilia and pregnancy loss

Area of Science:

• Reproductive Medicine
• Hematology
• Thrombosis Research

Background:

• Thrombophilia, characterized by a tendency towards thrombosis, is increasingly recognized for its impact on pregnancy outcomes.
• While antiphospholipid antibodies (aPL) are established acquired thrombophilic defects linked to pregnancy loss, the role of other hemostatic defects requires further elucidation.
• Recurrent miscarriage necessitates comprehensive investigation into potential underlying causes, including thrombotic predispositions.

Purpose of the Study:

• To review recent advancements in understanding antiphospholipid antibody-related pregnancy loss.
• To examine the association between inherited thrombophilic mutations and pregnancy outcomes.
• To discuss the utility of whole blood hemostasis testing in evaluating women with recurrent miscarriage.

Main Methods:

• Literature review of recent studies on thrombophilia and pregnancy loss.
• Analysis of data concerning antiphospholipid antibodies and genetic thrombophilic mutations.
• Evaluation of the role of whole blood hemostasis testing in clinical practice.

Main Results:

• Antiphospholipid antibodies are significantly associated with adverse pregnancy outcomes.
• The contribution of other inherited thrombophilic defects to pregnancy loss is still under investigation.
• Whole blood hemostasis testing may offer valuable insights into recurrent miscarriage.

Conclusions:

• Antiphospholipid antibodies represent a key acquired thrombophilia linked to pregnancy loss.
• Further research is needed to clarify the role of genetic thrombophilia in pregnancy complications.
• Whole blood hemostasis testing is a promising tool for investigating recurrent miscarriage in women with suspected thrombophilia.